Kate Sasser, Ph. D. is Vice President, Oncology Translational Research, at Janssen Research & Development, LLC. She leads the translational research teams for the three oncology Disease Area Strongholds (DAS; lung, prostate and hematologic malignancies), as well as the Computational Biology and Operations teams.
Kate joined Janssen Research & Development in 2012, as an Associate Director and was a member of the Oncology Translational Research group supporting the hematologic malignancy DAS. She led that team in 2014-16 and has made major contributions to many of our hematologic malignancy programs. She was honored with the 2016 Johnson Medal, the highest award across Johnson & Johnson’s R&D organizations.
Prior to joining Janssen Research & Development, Kate led a new group at Lab Connect, LLC, focused on providing translational scientific services for pharmaceutical and biotech companies.
Kate earned her Bachelor of Science. in Microbiology and Chemistry from Oregon State University, Corvallis, Oregon, and her Ph.D. in Biomedical Sciences from the Ohio State University, Columbus, Ohio. She has worked in translational science for more than 15 years as an academic researcher and as a biotechnology and pharmaceutical scientist.